AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Young professionals can benefit from targeted wealth growth tips. Learn how to maximize your earnings and investments.
22,851 articlesAbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Nscale raised billions to power Europe’s AI ambitions, but the company now confronts the need to prove it can transla...
Fidelity’s Q1 2026 data show the average IRA balance climbing to $131,380 as contributions surge. Yet the gap between...
Stocks paused after a sharp tech selloff, led by Micron and Intel. Yet one tech name stood out, bucking the trend as ...
Analysts are signaling a renewed appetite for Meta Platforms as ad revenue reaccelerates and AI products expand. The ...
A retiree faces a hefty tax bill after a large Roth conversion, prompting advisors to stress careful timing and stage...
A robotics wave is reshaping American productivity, with big investments and bold forecasts. Yet policy, skills, and ...
iQIYI’s stock trades near $1 after a disappointing Q1 report, but the company’s AI pivot and new capital moves set up...
As 2028 approaches, pre-retirees face a pivotal window to optimize savings, reduce risk, and improve retirement incom...
In 2026, union plumbers using a stacked retirement strategy can outpace many nonunion shop owners. A triple-pillared ...
As Brazil begins a measured rate-cut cycle, EWZ may emerge as a tactical edge in 2026. A slower Fed and a stronger BR...
A volatile day in the stock market today, july features a notable drop for Eos Energy after project news. Learn what ...